STE
Steris Plc

382
Loading...
Loading...
News
all
press releases
Should You Hold STERIS Stock in Your Portfolio Right Now?
STE posts solid Healthcare and AST growth with strong liquidity but faces macroeconomic and currency headwinds.
Zacks·10d ago
News Placeholder
More News
News Placeholder
SOLV Strong Q2 Results Signal Momentum: Is the Stock Worth Buying Now?
Solventum beats on Q2 earnings, raises guidance, and powers ahead with transformation despite looming tariff headwinds.
Zacks·17d ago
News Placeholder
Here's Why Steris (STE) is a Strong Growth Stock
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Zacks·18d ago
News Placeholder
Why Steris (STE) is a Top Momentum Stock for the Long-Term
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Zacks·1mo ago
News Placeholder
Why Steris (STE) is a Top Growth Stock for the Long-Term
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Zacks·1mo ago
News Placeholder
Here's Why Steris (STE) is a Strong Growth Stock
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Zacks·2mo ago
News Placeholder
Understanding Steris (STE) Reliance on International Revenue
Examine the evolution of Steris' (STE) overseas revenue trends and their effects on Wall Street's forecasts and the stock's prospects.
Zacks·2mo ago
News Placeholder
STE Beats on Q1 Earnings and Revenues, Raises '26 Sales View
STERIS posts 15% EPS growth and raises FY26 revenue outlook, with all segments showing solid year-over-year gains.
Zacks·2mo ago
News Placeholder
Compared to Estimates, Steris (STE) Q1 Earnings: A Look at Key Metrics
The headline numbers for Steris (STE) give insight into how the company performed in the quarter ended June 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Zacks·2mo ago
News Placeholder
Steris (STE) Tops Q1 Earnings and Revenue Estimates
Steris (STE) delivered earnings and revenue surprises of +0.86% and +2.36%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·2mo ago

Latest STE News

View

Advertisement|Remove ads.

Advertisement|Remove ads.